Next Article in Journal / Special Issue
Clinical Expectations for Better Influenza Virus Vaccines—Perspectives from the Young Investigators’ Point of View
Previous Article in Journal
Enhanced Anti-Mycobacterium tuberculosis Immunity over Time with Combined Drug and Immunotherapy Treatment
Previous Article in Special Issue
Clinical Advances in Viral-Vectored Influenza Vaccines
Article Menu

Export Article

Open AccessReview
Vaccines 2018, 6(2), 31; https://doi.org/10.3390/vaccines6020031

Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy

Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 50 South Drive, Room 6351, Bethesda, MD 20892, USA
*
Author to whom correspondence should be addressed.
Received: 17 March 2018 / Revised: 11 May 2018 / Accepted: 21 May 2018 / Published: 25 May 2018
Full-Text   |   PDF [4212 KB, uploaded 25 May 2018]   |  

Abstract

Influenza viruses affect millions of people worldwide on an annual basis. Although vaccines are available, influenza still causes significant human mortality and morbidity. Vaccines target the major influenza surface glycoprotein hemagglutinin (HA). However, circulating HA subtypes undergo continual variation in their dominant epitopes, requiring vaccines to be updated annually. A goal of next-generation influenza vaccine research is to produce broader protective immunity against the different types, subtypes, and strains of influenza viruses. One emerging strategy is to focus the immune response away from variable epitopes, and instead target the conserved stem region of HA. To increase the display and immunogenicity of the HA stem, nanoparticles are being developed to display epitopes in a controlled spatial arrangement to improve immunogenicity and elicit protective immune responses. Engineering of these nanoparticles requires structure-guided design to optimize the fidelity and valency of antigen presentation. Here, we review electron microscopy applied to study the 3D structures of influenza viruses and different vaccine antigens. Structure-guided information from electron microscopy should be integrated into pipelines for the development of both more efficacious seasonal and universal influenza vaccine antigens. The lessons learned from influenza vaccine electron microscopic research could aid in the development of novel vaccines for other pathogens. View Full-Text
Keywords: influenza; vaccines; structure; electron microscopy; cryo-EM; design influenza; vaccines; structure; electron microscopy; cryo-EM; design
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Gallagher, J.R.; McCraw, D.M.; Torian, U.; Gulati, N.M.; Myers, M.L.; Conlon, M.T.; Harris, A.K. Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy. Vaccines 2018, 6, 31.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top